Asthma is a chronic lung disease characterized by inflammation of the air passages. C.O.P.D. is characterized by restricted airflow into and out of the lungs and loss of lung function over time.
We address these two therapy markets with a range of devices based on metering valves for pMDIs, Dry Powder Inhalers (DPIs), and mechanical and electronic add-on devices. To help improve patient compliance we are focusing significant resources on the development of mechanical and electronic peripheral devices such as dose indicators and counters.